Reuters logo
BRIEF-Molecular Partners regains rights to multi-DARPin drug candidate
2016年10月6日 / 凌晨5点31分 / 1 年前

BRIEF-Molecular Partners regains rights to multi-DARPin drug candidate

Oct 6 (Reuters) - Molecular Partners AG :

* Molecular Partners regains rights to multi-DARPin drug candidate targeting IL-13 & IL-17 for pulmonary indications from Janssen

* Termination of collaboration with Janssen in immunology does not impact Molecular Partners’ strategy Source text for Eikon: Further company coverage: (Gdynia Newsroom)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below